PHARMA ONLINE WHITE PAPERS

  • The GxP Digital Maturity Model
    8/8/2025

    Explore how the GMP Digital Maturity Model guides life sciences companies through five stages to improve compliance, efficiency, and profitability with strategic digital adoption.

  • Antibody-Drug Conjugates – Catalysts For Chemistry
    5/16/2024

    Review the complexities of developing linkers – chemical moieties which attach a drug payload to an antibody – and considerations when identifying a CRO for ADC research and development.

  • The Open Standard For Plug-And-Produce
    4/14/2026

    Take a look at how standardized, modular production simplifies line integration, reduces engineering effort, and enables faster changeovers. Ideal for teams seeking flexible manufacturing models.

  • Driving Digital Excellence In Life Sciences
    7/1/2025

    The life sciences industry is rapidly evolving through digital transformation and agility. Discover why embracing modern technologies is essential to thrive in today’s competitive landscape.

  • The 5 Ws Of A Human Factors Strategy
    3/31/2025

    A human factors strategy ensures medical products are safe, effective, and compliant by integrating user-focused design early, reducing risks, and optimizing regulatory approval processes.

Katie-Anderson-Chief-Editor

INDUSTRY NEWS

  • Høeg In, Pazdur Out At The FDA

    What an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.

  • 9 Drugs Granted Fast Track By FDA's Voucher Program

    With targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.

  • Leaders In The Excipient Market: Region And Type

    Though North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.

  • Pfizer Strengthens Obesity Foothold With Metsera Acquisition

    After discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.

  • FDA Cracks Down On GLP-1 Imports

    GLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.

PHARMACEUTICAL ONLINE CONTENT COLLECTIONS

MilliporeSigma Pharm Online Ebook

 

Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.

More Content Collections

SUPPLIER NEWS